Safety and effectiveness of rosuvastatin versus rosuvastatin with fenofibrate in patients with dyslipidemia.
Not Applicable
- Conditions
- Health Condition 1: E785- Hyperlipidemia, unspecified
- Registration Number
- CTRI/2024/07/070696
- Lead Sponsor
- Dr Shivam Yadav
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Either gender aged 18 to 70 years .
Patients giving written informed consent will be taken.
Hypertensive patients.
Exclusion Criteria
Patient not willing to participate in the study.
Active liver disease.
Preexisting gallbladder disease.
Type 1 diabetes mellitus.
Thyroid dysfunction.
Type 2 diabetes mellitus.
Any malignancies.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Quality of lifeTimepoint: Baseline, 2 months, 3 months
- Secondary Outcome Measures
Name Time Method Adverse drug reactionTimepoint: At 2nd and 3rd month